<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2018.81001</article-id><article-id pub-id-type="publisher-id">JDM-81779</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Assessment of the Podiatric Risk on Diabetics in Dakar Hospital Area: Cross-Sectional Study in Regard to 142 Patients
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Leye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngone</surname><given-names>Diaba Diack</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yakham</surname><given-names>Mohamed Leye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nafy</surname><given-names>Ndiaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alex</surname><given-names>Bahati</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ameth</surname><given-names>Dieng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daouda</surname><given-names>Thioub</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maïmouna</surname><given-names>Senghor</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maouly</surname><given-names>Fall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samira</surname><given-names>Elfajri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Internal Medicine/Endocrinology-Diabetology Department, Teaching Hospital of Pikine, Dakar, Senegal</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>ablayleye@hotmail.com(AL)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>01</month><year>2018</year></pub-date><volume>08</volume><issue>01</issue><fpage>1</fpage><lpage>8</lpage><history><date date-type="received"><day>25,</day>	<month>December</month>	<year>2017</year></date><date date-type="rev-recd"><day>13,</day>	<month>January</month>	<year>2018</year>	</date><date date-type="accepted"><day>16,</day>	<month>January</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The prevention of diabetic foot goes through a systematic podiatric assessment of diabetic patients permitting to identify the foot at risk. Then, we realized a study in the Internal Medicine Department at Pikine Teaching Hospital in Dakar with the assessment of foot risk on admitted diabetic patients as our main objective. 
  <b>Methods</b>
  : It was about a prospective cross-sectional, descriptive and analytic study done on 18
   
  months period. <b>Results</b>: Overall, 142 patients were gathered. The average age was 56
  .
  22 years and the sex-ratio 
  was 
  0
  .
  67. 87.2% of the patients were running type 2 diabetes. The capillary blood glucose and glycated hemoglobin were respectively around 3
  .
  24
   
  g/L and 9%. High Blood Pressure was found in 62% of cases. The type of footwear most used by our patients was sandals (96
  .
  3%). Also, 30
  .
  6% of patients walked barefoot. Prior ulceration and/or amputation were noted in 30% of cases. During the foot examination, a lesion was found in 15
  .
  5% of patients. Loss of monofilament sensitivity was about 66
  .
  7%. The Ankle-Brachial Index (ABI) less than 0
  .
  9 was recorded in 34% of patients and at least a quarter of patients were posterior
  ly
   tibial pulselessness. The gradation of the foot risk according to the International Working Group of the Diabetic Foot (IWGDF) was established as follow: grade 0 (58%), grade 1 (9
  .
  8%), grade 2 (14
  .
  3%), grade 3 (17
  .
  3%). The presence of neuropathy
   
  (OR 12
  . 
  162 [3
  .
  368 
  -
   43
  .
  923]; p
   
  = 0
  .
  000), plantar keratosis
   
  (OR 2
  .
  87 [1
  .
  119 
  -
   7
  .
  399]; p
   
  = 0
  .
  024)
   
  and the absence of pulse perception (OR 9
  .
  00 [3
  .
  205 
  -
   25
  .
  414]; p
   
  = 0
  .
  000)
   
  were significant associated factors of foot injury occurrence on our patients. <b>Conclusion</b>: The prevention of diabetic foot in emerging countries is accessible by a systematic clinical examination of all diabetic feet and the awareness of adapted footwear.
 
</p></abstract><kwd-group><kwd>Foot Risk</kwd><kwd> Diabetes</kwd><kwd> Dakar</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Foot injuries on diabetics are the first non-traumatic cause of lower limbs amputation [<xref ref-type="bibr" rid="scirp.81779-ref1">1</xref>] . In Africa, the socio-economical precariousness and the diagnostic delay of the diabetes are both risk factors of diabetic foot occurrence [<xref ref-type="bibr" rid="scirp.81779-ref1">1</xref>] . In Senegal, this complication represents 2.8% of the complaints in diabetology [<xref ref-type="bibr" rid="scirp.81779-ref2">2</xref>] .</p><p>Diabetic foot is a public health issue by its prevalence but also the cost of the management and the functional disability it causes. Therefore, it’s necessary to prevent its occurrence by a systematic foot examination. This examination allows an assessment of the foot risk and the screening of early lesions [<xref ref-type="bibr" rid="scirp.81779-ref3">3</xref>] .</p><p>In this perspective, we initiated this prospective study in Dakar hospital area. It was about evaluating the podiatric risk on admitted diabetic patients at the Internal Medicine/Diabetology Department in Pikine Teaching Hospital of Dakar. This study should also allow to identify the associated factors of foot lesion occurrence in this population.</p></sec><sec id="s2"><title>2. Methodology</title><p>It was about a cross-sectional, prospective, descriptive and analytical study that happened in a 18-months (period from January 1st to June 30th 2014). It concerned diabetic individuals hospitalized in the Internal Medicine Unit of CNHP during the study. Patients were recruited after their oral consent. Patients who didn’t accept or who couldn’t be examined were not included. Data regarding their status, diabetic field, podiatric risk factors and foot examination results were noted in a record card. After these data, a foot risk gradation was set according to the International Consensus on Diabetic Foot approved by the International Working Group on the Diabetic foot [<xref ref-type="bibr" rid="scirp.81779-ref4">4</xref>] .</p><p>Data were analyzed afterwards by a software SPSS version 20.0. The proportion was considered as significant for a value less than 0.05.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Epidemiological Data</title><p>Overall 142 files were collected during the study. The average age of the patients was 56.22 years old with extremes of 16 and 85 years. Sex ratio male/female was 0.67.</p></sec><sec id="s3_2"><title>3.2. Data Regarding Diabetic Field</title><p>Type 2 diabetes represented 87% of the cases against 11% of type 1 diabetes. Recent discovery of the diabetic status occurred in 30 patients. It has been known and treated for more than 10 years in around half of the included individual (49%). Among the patients already known diabetics, before their admission (n = 112), 38.4% were under insulin and 67% with non-insulinic treatment, particularly with Metformin (42%). Capillary blood glucose while admission was at average 3.24 g/L. Glycated hemoglobin (HbA1C) was over than 7% in more than three quarters of cases (76.5%) when checked. The average in our study was 9% [extremes 5% - 14%].</p><p>Others cardiovascular associated risk factors were noted such as hypertension mainly in 62% of patients, smoking (15.5%), overweight (23%) and obesity (18%).</p></sec><sec id="s3_3"><title>3.3. Podiatric Risk Factors</title><p>The most used footwear type by our patients was sandals (96.3%). Patients who walked barefoot represented 30.6% in our series (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Patients with closed shoe were 28.9% of the cases. Diabetic individuals in our series didn’t wear shoes in 62.1% of the cases. Prior ulcerations and amputations were respectively found in 34 patients (24%) and 5.9% of cases. Gait disorders were noted on 19 patients around 13.4%. Traumatic pedicure cares were realized on around 20% of our patients.</p></sec><sec id="s3_4"><title>3.4. Local Foot Examination Results</title><p>The main noted abnormalities during foot examination in our patients are highlighted in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Cutaneous trophic disorders were essentially as skin depilated, cardboard, waxy and/or fine. A foot lesion was recorded in 22 patients (15.5%) with 12 men and 10 women. The average age was 58.59 years and they were type 2 diabetics in 95.5% of the cases. The hallmarks of the found lesions are set in <xref ref-type="table" rid="table1">Table 1</xref>. Lesions were like ulcerations, often associated with necrosis (<xref ref-type="fig" rid="fig3">Figure 3</xref>), gangrene (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and abscess.</p><p>Monofilament sensitivity was missing in 66.7% of our patients and uninterpretable in 19% of patients. In 22 patients having a foot lesion, the sensibility was missing in 14 and uninterpretable in 4 of them.</p><p>The Ankle-Brachial Index (ABI) was low (less than 0.9) in 48 patients. Pulseless regarded particularly posterior tibial pulse that was perceived in 26.1% of the cases.</p><p>The foot risk gradation in our patients according to the IWGDF is set in <xref ref-type="fig" rid="fig5">Figure 5</xref>. Patients with feet at podiatric risk represented 58.7% in our series.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Hallmarks of diabetic foot in our series</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"  >WORKFORCE</th><th align="center" valign="middle" >PERCENTAGE</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >Type of lesion</td><td align="center" valign="middle" >Ulceration</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >63.6</td></tr><tr><td align="center" valign="middle" >Gangrene</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >40.9</td></tr><tr><td align="center" valign="middle" >Abscess</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Number of lesions</td><td align="center" valign="middle" >Unique</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >81.8</td></tr><tr><td align="center" valign="middle" >Multiple</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >18.2</td></tr><tr><td align="center" valign="middle"  rowspan="6"  >Lesion localisation</td><td align="center" valign="middle" >Toes</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >22.7</td></tr><tr><td align="center" valign="middle" >Sole</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >40.9</td></tr><tr><td align="center" valign="middle" >Back of the foot</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >Malleolus</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >27.2</td></tr><tr><td align="center" valign="middle" >Heel</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >9.1</td></tr><tr><td align="center" valign="middle" >Leg</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Evolutionary stages lesions</td><td align="center" valign="middle" >Yellow</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >86.4</td></tr><tr><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >36.4</td></tr><tr><td align="center" valign="middle" >Red</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >18.2</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Bone and articulation visibilty</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >9.1</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >90.9</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Lesion aspect</td><td align="center" valign="middle" >Fibrinous</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >45.5</td></tr><tr><td align="center" valign="middle" >Wet</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >36.4</td></tr><tr><td align="center" valign="middle" >Dry</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >40.9</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Borders</td><td align="center" valign="middle" >Unstuck</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >9.1</td></tr><tr><td align="center" valign="middle" >shredded</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >36.4</td></tr><tr><td align="center" valign="middle" >Well limited</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >54.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Communicating injuries</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >86.4</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Local inflammatory signs</td><td align="center" valign="middle" >Purulent discharge</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >27.3</td></tr><tr><td align="center" valign="middle" >Deep wound</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >68.2</td></tr><tr><td align="center" valign="middle" >Nasty smelt</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >45.5</td></tr><tr><td align="center" valign="middle" >Local heat</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >54.5</td></tr><tr><td align="center" valign="middle" >Redness</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >22.7</td></tr><tr><td align="center" valign="middle" >Bone contact</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >9.1</td></tr></tbody></table></table-wrap></sec><sec id="s3_5"><title>3.5. Analytical Study</title><p>The main factors significantly associated with the presence of a foot lesion in our series are listed in <xref ref-type="table" rid="table2">Table 2</xref>. Among them, only the wear of closed shoe had a protective effect on lesion occurrence. The existence of neuropathy was an important factor associated to the occurrence of diabetic foot in our patients.</p><p>This neuropathy was significantly and positively correlated at an age over than 55 years (OR: 2.773 [IC 95%: 1.121 - 6.856]; p = 0.024), a diabetes evolving since more than 5 years (OR: 5.230 [IC 95%: 2.438 - 11.215]; p = 0.000), presence of hyperglycaemic imbalance (OR: 2.773 [IC 95%: 1.121 - 6.856]; p = 0.024) and an associated hypertension (OR: 2.782 (IC 95%: 1.312 - 5.900]; p = 0.007).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Our study gathered 142 patients aged on average over 55 years with a female predominance. This female predominance in this diabetic population has been already reported in our context [<xref ref-type="bibr" rid="scirp.81779-ref5">5</xref>] .</p><p>More of our patients were type 2 diabetic. This diabetes has been known for more than 10 years on around half of them. The glycated haemoglobin average at 9% and the blood capillary glucose at 3.24 g/L in our studied population witness the bad glycaemic balance of our patients. High Blood Pressure was the main associated cardiovascular risk factor in our series.</p><p>Several foot risk factors were present in our patients. It was about the use of unsuitable shoes particularly sandals and slippers. Also, more than 30% of our patients walked barefoot. However, this barefoot walking didn’t significantly have an impact on the risk of foot lesion in our study contrary to what was report by the literature [<xref ref-type="bibr" rid="scirp.81779-ref6">6</xref>] . One should also point out the high prevalence of podiatric histories at risk such as prior foot ulceration and/or amputation found in 30% of the cases. Others foot risks such as neuropathy and arteritis were also checked in our patients. Therefore, the sensitivity on monofilament was missing in more than 60% of the cases.</p><p>The ABI was low in 34% of the cases and at least a patient out of four presented an abolition of the posterior tibial pulse which the specificity for the diabetic arteriopathy was highlighted [<xref ref-type="bibr" rid="scirp.81779-ref7">7</xref>] . Therefore, according to the IWGDF, over than 30% of our population of study were at a high foot risk. In a recent Tunisian study, a comparable amount was recorded (32.6%) [<xref ref-type="bibr" rid="scirp.81779-ref8">8</xref>] . These data could be explained by the high prevalence of podiatric risk factors in our populations. The identification and the management of those factors are then unavoidable in</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Factors significantly associated with a diabetic foot in our series</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Factors studied</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >OR (IC 95%)</th></tr></thead><tr><td align="center" valign="middle" >Wearing closed shoes</td><td align="center" valign="middle" >0.026</td><td align="center" valign="middle" >0.075 [0.006 - 0.954]</td></tr><tr><td align="center" valign="middle" >Plantar keratosis</td><td align="center" valign="middle" >0.024</td><td align="center" valign="middle" >2.878 [1.119 - 7.399]</td></tr><tr><td align="center" valign="middle" >Absent monofilament sensation</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >12.162 [3.368 - 43.923]</td></tr><tr><td align="center" valign="middle" >Absence of pulse perception</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >9.026 [3.205 - 25.414]</td></tr></tbody></table></table-wrap><p>the prevention of diabetic foot in our country.</p><p>The prevalence of the foot lesions in our study was estimated at 15.5%. The average age of these patients was around 60 years and type 2 diabetics were predominant. This prevalence is close to the one recorded in prior African studies to ours [<xref ref-type="bibr" rid="scirp.81779-ref9">9</xref>] . In two-third of cases, these lesions were as ulceration. Plantar and toes localisation of these lesions correspond at what is classically reported in the literature [<xref ref-type="bibr" rid="scirp.81779-ref10">10</xref>] . Therefore, it’s the areas of predilection that should attract a particular attention of the clinician while examining diabetic patients.</p><p>In our study, foot lesion risk factors were dominated by neuropathy, plantar keratosis and the absence of pulse perception. The presence of neuropathy is the main pathophysiological mechanism involved in the occurrence of ulceration on the diabetic patient [<xref ref-type="bibr" rid="scirp.81779-ref11">11</xref>] . The diagnosis of diabetic neuropathy by baresthesia defect after application of monofilament 10 g on the foot (Semmes-Weinstein 5.07) has an excellent sensibility and specificity to predict the foot ulceration risk [<xref ref-type="bibr" rid="scirp.81779-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.81779-ref12">12</xref>] . In our study population, neuropathy was more observed in 55-year-old individuals, with diabetes for more than 5 years, with associated hypertension and hyperglycaemic imbalance as demonstrated in the literature [<xref ref-type="bibr" rid="scirp.81779-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.81779-ref14">14</xref>] . In addition, wearing closed shoes was a protective factor for foot injury in our study population. Thus, targeted prevention measures are possible in our context, in particular by the management of plantar keratosis, the screening and monitoring of neuropathy and raising awareness of patients for the use of adapted footwear.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The importance of preventing the diabetic foot and the heavy morbidity and mortality that accompany it is well established. This prevention involves the identification and early management of risky feet. Our study shows that the podiatric risk of our diabetic inpatients is high. This risk is explained by the strong presence of foot risk factors such as inadequate footwear and especially the existence of neuropathy. Preventive measures are therefore recommended in the follow-up of diabetic patients, in particular by performing the monofilament test and raising awareness about the wearing of suitable shoes.</p></sec><sec id="s6"><title>Cite this paper</title><p>Leye, A., Diack, N.D., Leye, Y.M., Ndiaye, N., Bahati, A., Dieng, A., Thioub, D., Senghor, M., Fall, M. and Elfajri, S. (2018) Assessment of the Podiatric Risk on Diabetics in Dakar Hospital Area: Cross-Sectional Study in Regard to 142 Patients. Journal of Diabetes Mellitus, 8, 1-8. https://doi.org/10.4236/jdm.2018.81001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.81779-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Dehayem, M.Y., Choukem, S.P. and Sobngwi, E. (2016) Offloading of Diabetic Foot Ulcers in Limited Resource Settings. Medecine des Maladies Metaboliques, 10, 555-559.</mixed-citation></ref><ref id="scirp.81779-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mbaye, N.M., Sarr, A., Diop, S.N., et al. (2008) Descriptive Study of Diabetic Foot at the Marc Sankale Diabetes Center. Dakar Medical, 53, 205-212.</mixed-citation></ref><ref id="scirp.81779-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bakker, K., Apelqvist, J., Lipsky, B.A. and Van Netten, J.J. (2016) The 2015 IWGDF Guidance Documents on Prevention and Management of Foot Problems in Diabetes: Development of an Evidence-Based Global Consensus. Diabetes/Metabolism Research and Reviews, 32, 2-6. https://doi.org/10.1002/dmrr.2694</mixed-citation></ref><ref id="scirp.81779-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Apelqvist, J., Bakker, K., van Houtum, W.H., Schaper, N.C., on behalf of the International Working Group on the Diabetic Foot (IWGDF) Editorial Board. (2008) Practical Guidelines on the Management and Prevention of the Diabetic Foot. Diabetes/Metabolism Research and Reviews, 24, S181-S187.  
https://doi.org/10.1002/dmrr.848</mixed-citation></ref><ref id="scirp.81779-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Diop, S.N., Wade, A., Lokrou, A., et al. (2013) Management of Type 2 Diabetes in Clinical Practices in Sub-Saharan Africa: Results of the AMAR-AFO Study in Senegal and Ivory Cost. Medecine des Maladies Metaboliques, 7, 363-367.</mixed-citation></ref><ref id="scirp.81779-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ogbera, O.A., Osa, E., Edo, A., et al. (2008) Common Clinical Features of Diabetic Foot Ulcers: Perspectives from a Developing Nation. The International Journal of Lower Extremity Wounds, 7, 93-98. https://doi.org/10.1177/1534734608318236</mixed-citation></ref><ref id="scirp.81779-ref7"><label>7</label><mixed-citation publication-type="book" xlink:type="simple">Hartemann, A., Lecornet-Sokol, E. and Halbron, M. (2010) Arteriopathy of the Lower Limbs and Diabetes. In: Monnier, L., Ed., Diabétologie, Elsevier Masson, Paris, 263-271.</mixed-citation></ref><ref id="scirp.81779-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Feleh, E.E., Bchir, N., Jaidane, A., et al. (2017) Podiological Risk Assessment in Diabetic Patients. Annales d’Endocrinologie, 78, 431.</mixed-citation></ref><ref id="scirp.81779-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ndip, E.A., Tchakonte, B. and Mbanya, J.C. (2006) A Study of the Prevalence and Risk Factors of Foot Problems in a Population of Diabetic Patients in Cameroon. The International Journal of Lower Extremity Wounds, 5, 83-88.  
https://doi.org/10.1177/1534734606288413</mixed-citation></ref><ref id="scirp.81779-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Richard, J.L., Lavigne, J.P., Got, I., et al. (2011) Management of Patients Hospitalized for Diabetic Foot Infection: Results of the French OPIDIA Study. Diabetes &amp; Metabolism, 37, 208-215. https://doi.org/10.1016/j.diabet.2010.10.003</mixed-citation></ref><ref id="scirp.81779-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Martini, J. (2008) Diabetic Foot: Detection and Prevention. La Revue de Médecine Interne, 29, S260-S263. https://doi.org/10.1016/S0248-8663(08)73954-7</mixed-citation></ref><ref id="scirp.81779-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cheong, J., Alexiadou, K. and Devendra, S. (2017) Absent Monofilament Sensation in a Type 2 Diabetic Feet. London Journal of Primary Care (Abingdon), 9, 73-76. 
https://doi.org/10.1080/17571472.2017.1370813</mixed-citation></ref><ref id="scirp.81779-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hu, Y., Bakhotmah, B.A., Alzahrani, O.H., et al. (2014) Predictors of Diabetes Foot Complications among Patients with Diabetes in Saudi Arabia. Diabetes Research and Clinical Practice, 106, 286-294. https://doi.org/10.1016/j.diabres.2014.07.016</mixed-citation></ref><ref id="scirp.81779-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bruce, S.G. and Young, T.K. (2008) Prevalence and Risk Factors for Neuropathy in a Canadian First Nation Community. Diabetes Care, 31, 1837-1841. 
https://doi.org/10.2337/dc08-0278</mixed-citation></ref></ref-list></back></article>